APA (7th ed.) Citation

Kean, L., Langston, A., Qayed, M., Khoury, J., Tiwari, D., Couture, C., . . . Horan, J. (2012). CD28-Directed T Cell Costimulation Blockade with Abatacept to Prevent GVHD During High-Risk Unrelated HSCT: A First-In-Disease Trial. Biology of Blood & Marrow Transplantation, 18(2), S365. https://doi.org/10.1016/j.bbmt.2011.12.429

Chicago Style (17th ed.) Citation

Kean, L.S, et al. "CD28-Directed T Cell Costimulation Blockade with Abatacept to Prevent GVHD During High-Risk Unrelated HSCT: A First-In-Disease Trial." Biology of Blood & Marrow Transplantation 18, no. 2 (2012): S365. https://doi.org/10.1016/j.bbmt.2011.12.429.

MLA (9th ed.) Citation

Kean, L.S, et al. "CD28-Directed T Cell Costimulation Blockade with Abatacept to Prevent GVHD During High-Risk Unrelated HSCT: A First-In-Disease Trial." Biology of Blood & Marrow Transplantation, vol. 18, no. 2, 2012, p. S365, https://doi.org/10.1016/j.bbmt.2011.12.429.